Division of Hematology/Oncology, The Hospital for Sick Children, Department of Pediatrics, University of Toronto, Toronto, Ontario, Canada.
Children's Cancer Centre, Royal Children's Hospital, Murdoch Children's Research Institute, University of Melbourne, Melbourne, Australia.
Clin Cancer Res. 2017 Jun 1;23(11):e32-e37. doi: 10.1158/1078-0432.CCR-17-0574.
Replication proofreading is crucial to avoid mutation accumulation in dividing cells. In humans, proofreading and replication repair is maintained by the exonuclease domains of DNA polymerases and the mismatch repair system. Individuals harboring germline mutations in genes involved in this process are at increased risk of early cancers from multiple organs. Biallelic mutations in any of the four mismatch repair genes , and result in one of the most aggressive childhood cancer predisposition syndromes, termed constitutional mismatch repair deficiency or constitutional mismatch repair deficiency syndrome (CMMRD). Data gathered in the last decade allow us to better define the clinical manifestations, tumor spectrum, and diagnostic algorithms for CMMRD. In this article, we summarize this information and present a comprehensive consensus surveillance protocol for these individuals. Ongoing research will allow for further definition of replication repair-deficient cancer syndromes, assessing the cost-effectiveness of such surveillance protocols and potential therapeutic interventions for these children and families.
复制校对对于避免分裂细胞中的突变积累至关重要。在人类中,校对和复制修复是由 DNA 聚合酶的外切酶结构域和错配修复系统维持的。携带有参与该过程的基因种系突变的个体患多种器官早期癌症的风险增加。任何四个错配修复基因中的双等位基因突变都会导致最具侵袭性的儿童癌症易感性综合征之一,称为组成型错配修复缺陷或组成型错配修复缺陷综合征(CMMRD)。过去十年收集的数据使我们能够更好地定义 CMMRD 的临床表现、肿瘤谱和诊断算法。本文总结了这些信息,并为这些个体提出了全面的共识监测方案。正在进行的研究将进一步定义复制修复缺陷癌症综合征,评估此类监测方案的成本效益以及这些儿童和家庭的潜在治疗干预措施。